Molecular Docking Analysis of Adhatoda vasica with Thromboxane A2 Receptor (TXA2R) (6IIU) and Antiviral Molecules for Possible Dengue Complications.

Q3 Pharmacology, Toxicology and Pharmaceutics
Pugazhenthan Thangaraju, Gopinathan N, Vijayakumar Ar, Meenalochini Prakash Gurunthalingam, Sree Sudha Ty, Sajitha Venkatesan, Eswaran Thangaraju
{"title":"Molecular Docking Analysis of <i>Adhatoda vasica</i> with Thromboxane A<sub>2</sub> Receptor (TXA<sub>2</sub>R) (6IIU) and Antiviral Molecules for Possible Dengue Complications.","authors":"Pugazhenthan Thangaraju,&nbsp;Gopinathan N,&nbsp;Vijayakumar Ar,&nbsp;Meenalochini Prakash Gurunthalingam,&nbsp;Sree Sudha Ty,&nbsp;Sajitha Venkatesan,&nbsp;Eswaran Thangaraju","doi":"10.2174/1871526522666220718101544","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The present study is an in silico model of platelet amplification potential of Adhatoda vasica, which can be used to treat thrombocytopenia in dengue complications.</p><p><strong>Methods: </strong>Docking studies have proved to be an essential tool that facilitates the structural diversity of natural products to be harnessed in an organized manner. In the present study, vasicine containing natural anti-dengue potential was subjected to docking studies using Schrodinger glides software (ver.11.1). The docking study was carried out to find out the potential molecular targets for selected protein. The docking was carried out on different ligands, like vasicine, ramatroban, chloroquine, celgosivir, and standard eltrombopag downloaded from PubChem and retrieved to glide software and ligands prepared using lig prep wizard. Docking was performed using the ligand docking wizard of Glide-maestro 2018.</p><p><strong>Results: </strong>The docking score of vasicine (-5.27) is nearly identical to the standard eltrombopag (-6.08), and both ligands bind with one hydrogen bond. The validation score of ramatroban is -12.39, binding with five hydrogen bonds, Celgosivir exhibited a docking score of -7.3 with three hydrogen bonds, and chloroquine displayed no hydrogen bond but had a docking score of -4.6.</p><p><strong>Conclusion: </strong>Vasicine was found to be the most suitable target of platelet amplification potential from Adhatoda vasica. However, the molecular docking results are preliminary, and it has been indicated that vasicine could be one of the potential ligands to treat the thrombocytopenia of dengue; experimental evaluation will be carried out in the near future.</p>","PeriodicalId":13678,"journal":{"name":"Infectious disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871526522666220718101544","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: The present study is an in silico model of platelet amplification potential of Adhatoda vasica, which can be used to treat thrombocytopenia in dengue complications.

Methods: Docking studies have proved to be an essential tool that facilitates the structural diversity of natural products to be harnessed in an organized manner. In the present study, vasicine containing natural anti-dengue potential was subjected to docking studies using Schrodinger glides software (ver.11.1). The docking study was carried out to find out the potential molecular targets for selected protein. The docking was carried out on different ligands, like vasicine, ramatroban, chloroquine, celgosivir, and standard eltrombopag downloaded from PubChem and retrieved to glide software and ligands prepared using lig prep wizard. Docking was performed using the ligand docking wizard of Glide-maestro 2018.

Results: The docking score of vasicine (-5.27) is nearly identical to the standard eltrombopag (-6.08), and both ligands bind with one hydrogen bond. The validation score of ramatroban is -12.39, binding with five hydrogen bonds, Celgosivir exhibited a docking score of -7.3 with three hydrogen bonds, and chloroquine displayed no hydrogen bond but had a docking score of -4.6.

Conclusion: Vasicine was found to be the most suitable target of platelet amplification potential from Adhatoda vasica. However, the molecular docking results are preliminary, and it has been indicated that vasicine could be one of the potential ligands to treat the thrombocytopenia of dengue; experimental evaluation will be carried out in the near future.

血管瓣蟾与血栓素A2受体(TXA2R) (6iu)及登革热可能并发症抗病毒分子的分子对接分析
目的:建立血管瓣血小板扩增电位的计算机模型,用于治疗登革热合并血小板减少症。方法:对接研究已被证明是促进天然产物结构多样性以有组织的方式利用的重要工具。在本研究中,利用薛定谔滑行软件(版本11.1)对含有天然抗登革热潜能的瓦西里疫苗进行对接研究。对接研究是为了寻找所选蛋白的潜在分子靶点。对接不同的配体,如从PubChem下载的vasicine、ramatroban、chloroquine、celgosivir和标准的eltrombopag,并检索到滑翔软件和使用light prep wizard制备的配体。对接使用Glide-maestro 2018的配体对接向导进行。结果:vasicine的对接分数(-5.27)与标准的eletrombopag的对接分数(-6.08)几乎相同,并且两种配体都与一个氢键结合。拉马托班的验证评分为-12.39,与5个氢键结合,Celgosivir与3个氢键的对接评分为-7.3,氯喹没有氢键,但对接评分为-4.6。结论:Vasicine是最合适的血小板扩增电位靶点。然而,分子对接结果是初步的,表明vasicine可能是治疗登革热血小板减少症的潜在配体之一;实验评估将在不久的将来进行。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infectious disorders drug targets
Infectious disorders drug targets Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
3.10
自引率
0.00%
发文量
123
期刊介绍: Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continues to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信